Changes of dipeptidyl peptidase IV (DPP-IV) in obese children with weight loss: relationships to peptide YY, pancreatic peptide, and insulin sensitivity
Blood 138 , 12111224 (2021)
Researchers are also studying retatrutide in metabolic-associated fatty liver disease, reflecting how broadly its mechanisms reach across metabolic health
Could we one day have a point-of-care test to be able to say I know whats going to happen to you, youre going to be a superresponder or a poor responder, youre going to be a person who gains back the weight quickly or youre going to be able to maintain. This is a great opportunity for future research. Genetics-based research has been conducted, but it could not find a genetic variation that explained these differences in response to GLP-1s, Drucker said
En pacientes DM2 con obesidad En general, no son aconsejables los frmacos que incrementan el peso (sulfonilureas, repaglinida, pioglitazona, insulina)